Background: Elevated Lp-PLA2 activity, a marker of inflammation and oxidative stress, is linked to increased cardiovascular disease (CVD) risk in type 2 diabetes mellitus (T2DM). This evidence concerns the gene PLA2G7 and diabetes mellitus.